Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal cell carcinoma: basic biology and clinical behavior

J R Franklin1, R Figlin, A Belldegrun

  • 1Department of Surgery, UCLA Kidney Cancer Program, USA.

Seminars in Urologic Oncology
|November 1, 1996
PubMed
Summary

Renal cell carcinoma (RCC) incidence is rising, with molecular genetics improving understanding of familial and sporadic forms. Immunotherapy shows promise for advanced disease, but other treatments remain limited.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

T-cell recruitment: a tool for specific immunosuppression.

Immunology today·2014
Same author

Immunotherapy and gene therapy for genitourinary malignancies.

International journal of urology : official journal of the Japanese Urological Association·2013
Same author

Interferon Alpha, GM-CSF-Activated T Cells, and IL-6 in Renal Cell Carcinoma.

Methods in molecular medicine·2011
Same author

Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis.

British journal of cancer·2006
Same author

Therapeutic strategies, predicting outcomes in patients with renal cell and transitional cell carcinomas.

Reviews in urology·2006

Area of Science:

  • Oncology
  • Molecular Genetics
  • Cancer Epidemiology

Background:

  • Renal cell carcinoma (RCC) incidence is increasing, posing a significant mortality risk.
  • Advances in imaging (ultrasonography, CT) lead to more incidental renal tumor diagnoses.
  • Conflicting evidence exists regarding early diagnosis trends and changes in RCC's natural history.

Purpose of the Study:

  • To review the current understanding of renal cell carcinoma (RCC) molecular genetics.
  • To explore the role of environmental factors and genetic disturbances in RCC.
  • To assess prognostic factors and treatment modalities for RCC.

Main Methods:

  • Review of current literature on renal cell carcinoma (RCC) epidemiology, genetics, and treatment.
  • Analysis of molecular and genetic findings related to RCC classification.
  • Evaluation of prognostic markers and therapeutic outcomes.

Main Results:

  • The von Hippel-Lindau (VHL) gene and chromosome 3p regions are crucial for understanding RCC genetics.
  • Molecular and genetic distinctions are being made between RCC cell types.
  • Environmental factors like smoking require further investigation for their link to genetic disturbances.
  • Current prognostic factors and molecular markers (e.g., p53, epidermal growth factor) lack convincing evidence.
  • Surgery is primary for organ-confined RCC; immunotherapy offers durable responses in advanced cases.

Conclusions:

  • Understanding RCC molecular genetics, particularly VHL and chromosome 3p, is advancing disease knowledge.
  • Further research is needed to link environmental factors to RCC genetic changes.
  • Immunotherapy presents a promising avenue for advanced renal cell carcinoma treatment.

Related Experiment Videos